In-depth: SA at cutting edge of TB vaccine research

In-depth: SA at cutting edge of TB vaccine research

It is a hundred years since the BCG vaccine, the only registered vaccine proven to offer some protection against tuberculosis (TB), was first used in people. Now researchers in South Africa are at the forefront of clinical trials testing experimental new TB vaccines. Adele Baleta reports.

Read More

COVID-19: Millions of injection devices will be needed for vaccines

COVID-19: Millions of injection devices will be needed for vaccines

The delivery of a safe and effective COVID-19 vaccine once it becomes available in South Africa will be a complex and costly logistical exercise. Acquiring enough injection devices is part of crucial logistical planning to ensure rapid, equitable access to COVID-19 vaccines. Adele Baleta reports.

Read More

IN-DEPTH: The slow motion race for a TB vaccine

IN-DEPTH: The slow motion race for a TB vaccine

In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.

Read More

COVID-19: Don’t take BCG vaccine away from kids who need it for TB, experts say

COVID-19: Don’t take BCG vaccine away from kids who need it for TB, experts say

The use of the BCG vaccine for an unproven indication is irresponsible and may deplete BCG stocks for young children, for whom it has been proven to be a lifesaving preventive tool against TB, argue a group of leading experts.

Read More